Verastem (NASDAQ:VSTM) said the FDA has accepted its New Drug Application for accelerated approval of its drugs avutometinib ...
Researchers from John Hopkins University and Stanford University built a training model using video recordings of ...
We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...
Further restrictions to California’s flavored tobacco ban will go into effect Jan. 1, with regulations being overseen by ...